SAGE RHINO CAPITAL LLC – Vertex Pharmaceuticals Incorporated Transaction History
SAGE RHINO CAPITAL LLC portfolio value:
$0
portfolio value
SAGE RHINO CAPITAL LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -934 shares | -263K | $289.54 | 0 |
| Q2 2022 | share | Decrease | -37.02% | -549 shares | -124K | $281.79 | 934 |
| Q1 2022 | share | Decrease | -5.60% | -88 shares | 42K | $260.97 | 1.48K |
| Q4 2021 | share | Increase | +1.75% | 27 shares | 65K | $222.45 | 1.57K |
| Q3 2021 | share | Increase | +1.51% | 23 shares | -27K | $181.39 | 1.54K |
| Q2 2021 | share | Increase | +0.53% | 8 shares | -18K | $201.63 | 1.52K |
| Q1 2021 | share | Increase | +21.23% | 265 shares | 30K | $214.89 | 1.51K |
| Q4 2020 | share | Increase | +10.25% | 116 shares | -13K | $236.34 | 1.24K |
| Q3 2020 | share | Increase | +8.74% | 91 shares | 6K | $272.12 | 1.13K |
| Q2 2020 | share | Increase | +2.66% | 27 shares | 61K | $290.31 | 1.04K |
| Q1 2020 | share | Decrease | -0.59% | -6 shares | 7K | $237.95 | 1.01K |
| Q4 2019 | share | Increase | 0.00% | 1.02K shares | 234K | $218.95 | 1.02K |